Suppr超能文献

葡萄糖调控血管基因表达的新型转录机制

A novel transcriptional mechanism of cell type-specific regulation of vascular gene expression by glucose.

机构信息

Department of Molecular Cardiology, Cleveland Clinic, Cleveland, OH 44195, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2011 Mar;31(3):634-42. doi: 10.1161/ATVBAHA.110.219675. Epub 2010 Dec 9.

Abstract

OBJECTIVE

Vascular diabetic complications are associated with abnormal extracellular matrix and dysfunction of vascular cells, which later result in aberrant angiogenesis and development of atherosclerotic lesions. The tissue and cell specificity of the effects of high glucose are well recognized, but the underlying cell type-specific molecular mechanisms controlled by glucose are still unclear. We sought to identify cell type-specific mechanisms by which high glucose regulates transcription of genes in vascular cells.

METHODS AND RESULTS

Thrombospondin-1 is a potent antiangiogenic protein associated with development of several diabetic complications and regulated by high glucose in multiple cell types. We report that distinct cell type-specific mechanisms regulate thrombospondin-1 gene (THBS1) transcription in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in response to high glucose: although a proximal fragment of 280 nucleotides is sufficient to drive transcription in ECs, THBS1 was regulated cooperatively by interaction between proximal (-272 to -275) and distal (-1016 to -1019) promoter elements in VSMCs. Transcription factors activated by high glucose in VSMCs were cell type-specific. The formation of a single complex interacting with both distal and proximal glucose-responsive elements of THBS1 promoter in VSMCs was confirmed using gel-shift assays, binding sequence decoy oligomers, and specific mutant promoter fragments.

CONCLUSIONS

Transcriptional response of vascular cells to high glucose is cell type-specific and involves activation of distinct transcription factors, providing a basis for tissue-specific changes of vasculature in diabetics.

摘要

目的

血管糖尿病并发症与细胞外基质异常和血管细胞功能障碍有关,这会导致血管生成异常和动脉粥样硬化病变的发展。高血糖对组织和细胞的影响具有特异性,但控制其影响的细胞类型特异性分子机制仍不清楚。我们试图确定高血糖调节血管细胞基因转录的细胞类型特异性机制。

方法和结果

血小板反应蛋白-1 是一种与多种糖尿病并发症相关的强效抗血管生成蛋白,并且在多种细胞类型中受到高葡萄糖的调节。我们报告说,在高葡萄糖刺激下,内皮细胞(ECs)和血管平滑肌细胞(VSMCs)中通过不同的细胞类型特异性机制调节血小板反应蛋白-1 基因(THBS1)转录:虽然 280 个核苷酸的近端片段足以在 ECs 中驱动转录,但在 VSMCs 中,THBS1 的转录受近端(-272 至-275)和远端(-1016 至-1019)启动子元件之间的相互作用协同调节。高葡萄糖在 VSMCs 中激活的转录因子是细胞类型特异性的。使用凝胶迁移分析、结合序列诱饵寡核苷酸和特定的突变启动子片段证实了在 VSMCs 中与 THBS1 启动子的远端和近端葡萄糖反应元件相互作用的单个复合物的形成。

结论

血管细胞对高葡萄糖的转录反应具有细胞类型特异性,涉及激活不同的转录因子,为糖尿病中血管的组织特异性变化提供了基础。

相似文献

引用本文的文献

2
Regulating islet stress responses through CD47 activation.通过CD47激活调节胰岛应激反应。
Diabetologia. 2025 Jun;68(6):1279-1297. doi: 10.1007/s00125-025-06409-3. Epub 2025 Mar 25.
8
miR-467 regulates inflammation and blood insulin and glucose.miR-467 调节炎症及血胰岛素和血糖。
J Cell Mol Med. 2021 Mar;25(5):2549-2562. doi: 10.1111/jcmm.16224. Epub 2021 Feb 10.

本文引用的文献

4
The aryl hydrocarbon receptor is activated by modified low-density lipoprotein.芳基烃受体可被修饰的低密度脂蛋白激活。
Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1412-7. doi: 10.1073/pnas.0607296104. Epub 2007 Jan 16.
7
Regulation of vascular genes by glucose.葡萄糖对血管基因的调控
Curr Pharm Des. 2005;11(18):2367-81. doi: 10.2174/1381612054367283.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验